INSIGHTi
COVID-19 Vaccination: Selected U.S. Data
Sources
Updated August 25, 2021
The sources below can help congressional staff track the progress of the U.S. Coronavirus Disease 2019
(COVID-19) vaccination campaign at the national, state, and local levels.
Sources were selected for having commonly cited and frequently requested data. This list is not intended
to be comprehensive. Because different resources use different methodologies, readers should check
websites’ notes and caveats, and use caution when comparing data. For assistance in interpreting or
analyzing these data, congressional staff should contact CRS (202) 707-5700, or place a request at CRS’s
website).
For an overview of data systems and considerations for Congress, see CRS Insight IN11584, Tracking
COVID-19 Vaccines: U.S. Data Systems and Related Issues.
Centers for Disease Control and Prevention’s (CDC’s) Vaccines for COVID-19 website can assist
constituents with questions about the vaccine and how to get vaccinated.
Example data sources on public attitudes toward vaccination include CDC’s National Immunization
Survey and State of Vaccine Confidence Insights Report, Census Bureau (HHS analysis), Kaiser Family
Foundation, Carnegie Mellon University, University of Washington, and scholarly articles.
About Vaccine Data
In the COVID-19 vaccine program, doses are first allocated and made available to states and other
jurisdictions for ordering. Once ordered, doses are delivered (i.e., distributed) to appropriate state and
jurisdictional sites. States then allocate and deliver doses to health departments, health care systems,
pharmacies, and multi-county entities, which can further re-allocate to local clinical sites. Providers then
administer doses to patients and report administration data to jurisdictions and CDC. (See CDC’s How
COVID-19 Vaccines Get to You and About COVID-19 Vaccine Delivered and Administration Data.)
Federal health care programs (e.g., Veterans Health Administration) manage vaccine data through a
similar process.
Comirnaty (formerly known as the Pfizer-BioNTech COVID-19 vaccine) is approved as a two-dose
vaccine for individuals aged 16+. Comirnaty remains authorized for emergency use only for individuals
Congressional Research Service
https://crsreports.congress.gov
IN11595
CRS INSIGHT
Prepared for Members and
Committees of Congress
link to page 2 link to page 4 Congressional Research Service
2
aged 12-15. Vaccines manufactured by Moderna (a two-dose vaccine) and J&J/Janssen (a single-dose
vaccine) are currently authorized for emergency use for individuals aged 18+. An additional dose of the
Moderna and Comirnaty/Pfizer-BioNTech vaccines is authorized for certain immunocompromised
individuals.
CDC Sources
CDC provides data on doses and people vaccinated, for the total population and populations aged 12+,
18+, and 65+. Some aggregated national data are available for federal entities (Bureau of Prisons,
Department of Defense, Indian Health Service, and Veterans Health Administration; see “Data Table”).
CDC also tracks hospitalized or fatal vaccine breakthrough infections. CDC continues to study vaccine
effectiveness in real-world conditions.
CDC (click map) compiles links to state dashboards, which may also track local data.
Non-CDC Sources
Non-CDC sources provide different visualizations and analyses of CDC data and incorporate data from
various jurisdiction-specific sources:
Bloomberg
Covid Act Now (and Harvard analysis with congressional district estimates)
Johns Hopkins University & Medicine (JHU)
Kaiser Family Foundation (KFF)
New York Times (NYT) (subscription required)
Washington Post (WP)
Centers for Medicare & Medicaid Services (CMS) posts nursing home-reported data.
Vaccination Data Sources
Table 1 links to websites containing specific vaccination statistics.
Table 1. Vaccination Data
(links to selected resources)
Measure
National
State
Local
Doses allocated
Numbera
KFF
CDC
KFF
Doses delivered
Number
CDC
CDC
NYT
NYT
WP
Per capita
CDC
By vaccine type (J&J/Janssen,
CDC
CDC (download Data Table)
Moderna, Comirnaty/Pfizer-
BioNTech)
link to page 4 link to page 4 link to page 4 link to page 4 link to page 4 link to page 4 link to page 4 link to page 4 link to page 4 Congressional Research Service
3
Measure
National
State
Local
By channel (channels include, e.g.,
CDC
jurisdictions, retail pharmacy
program, health centers program,
FEMA community vaccination
centers)
Doses administered
Number
CDC (also trend)
CDC (also trend)
Harvard (congressional
Bloomberg
Bloomberg
district)
JHU
JHU
NYT
NYT
Per capita
CDC
Per day (daily count and 7-day
CDCb
CDCb
average, trend)
Bloomberg
Bloomberg
KFFc
KFFc
NYT
WP
WP
By vaccine type
CDC
CDC (download Data Table)
NYT (trend)
Percentage of delivered doses that
Bloomberg (“Supply
CDC (first doses)
have been administered
used”)
CDC (see “Administration
NYT (“Doses used”)
Ratio: Overall Adjusted”)
Bloomberg (“Supply used”)
NYT (“Doses used”)
People vaccinated
People who received ≥1 dose
CDC (also trend)b
CDC (also trend)b
CDC (county)
(number)
WP (also trend)
WP (also trend)
CDC (CBSA)d
Harvard (congressional
district)
People who received ≥1 dose
CDC
CDC
CDC (county)
(percentage)
Bloomberg
Bloomberg
CDC (CBSA)d
Covid Act Now
Covid Act Nowe
Covid Act Now (city,
NYT (also trend)
NYT (also trend)
county)e
WP
WP
Harvard (congressional
district)
People fully vaccinatedf (number)
CDC (also trend)b
CDC (also trend)b
CDC (county)
JHU
JHU
CDC (CBSA)d
WP
WP
Harvard (congressional
district)
link to page 4 link to page 4 link to page 4 link to page 4 link to page 4 link to page 4 Congressional Research Service
4
Measure
National
State
Local
People fully vaccinatedf (percentage)
CDC
CDC
CDC (county, also case
Bloomberg
Bloomberg
rates and testing positivity
JHU
Covid Act Now
map)
e
NYT
JHU
CDC (CBSA)d
WP
NYT
Covid Act Now (city,
county)e
WP
Harvard (congressional
district)
NYT (county)
WP (county)
People fully vaccinatedf by vaccine
CDC
CDC (download Data Table)
type
Demographicsg
CDC (race/ethnicity,
CDC (aged 65+)
CDC (age, county and
sex, age; also trends)
Bloomberg (race/ethnicity)
CBSAd)
CDC (aged 65+)
KFF (race/ethnicity)
CDC (aged 65+, county)
CDC (trends by age,
NYT (age)
CDC (social vulnerability,
alongside cases)
county)
CDC (disability status
NYT (aged 65+, county)
and age,
race/ethnicity)
CDC (pregnant
people by
race/ethnicity, trend)
KFF (race/ethnicity)
NYT (age)
WP (race/ethnicity,
age trends)
Nursing homes
Percent of residents and staff fully
CMS
CMS
CMS (facility-level data in
vaccinated
“Search for a nursing
home”)
Source: CRS based on sources as of August 25, 2021.
Notes: Some sources report similar data, but with different visualizations and analysis.
a. Tables reflect federal allocations to jurisdictions, not other channels such as the retail pharmacy program.
b. See also 7-day average trend alongside cases or deaths, see “View (right axis).”
c. Click “Vaccines”: “Daily.”
d. Scroll to Excel spreadsheets. Metropolitan and Micropolitan Statistical Areas are collectively referred to as Core-
Based Statistical Areas (CBSAs).
e. Search state, city, or county, then scroll to “% Vaccinated” for trend.
f.
“Fully vaccinated” people have received the second dose of a two-dose vaccine or one dose of a single-shot vaccine
(CDC).
g. Not all states report demographics on vaccine recipients.
Congressional Research Service
5
Author Information
Ada S. Cornell
Angela Napili
Senior Research Librarian
Senior Research Librarian
Disclaimer
This document was prepared by the Congressional Research Service (CRS). CRS serves as nonpartisan shared staff
to congressional committees and Members of Congress. It operates solely at the behest of and under the direction of
Congress. Information in a CRS Report should not be relied upon for purposes other than public understanding of
information that has been provided by CRS to Members of Congress in connection with CRS’s institutional role.
CRS Reports, as a work of the United States Government, are not subject to copyright protection in the United
States. Any CRS Report may be reproduced and distributed in its entirety without permission from CRS. However,
as a CRS Report may include copyrighted images or material from a third party, you may need to obtain the
permission of the copyright holder if you wish to copy or otherwise use copyrighted material.
IN11595 · VERSION 12 · UPDATED